Data Loading...

Global myasthenia gravis treatment market is projected to grow at a considerable CAGR of around 7 Flipbook PDF

Global myasthenia gravis treatment market is projected to grow at a considerable CAGR of around 7


114 Views
82 Downloads
FLIP PDF 346.25KB

DOWNLOAD FLIP

REPORT DMCA

Orion Market Research

Global Myasthenia Gravis Treatment Market Size, Competitive Analysis, Share, Forecast- 2020-2026 Request a Free Sample @ https://www.omrglobal.com/request-sample/myasthenia-gravistreatment-market

Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +91 780-304-0404

Global myasthenia gravis treatment market is projected to grow at a considerable CAGR of around 7% during the forecast period (2020-2026). Increasing awareness related to the rare diseases, approval of promising drugs, the emergence of biologics along with the high adoption of immunotherapies is the key factor contributing towards the growth of the myasthenia gravis (MG) treatment market across the globe. Myasthenia gravis is a chronic autoimmune, neuromuscular disorder that leads to weakness in the skeletal muscles. Eyes, face, and swallowing are the most affected muscles. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/myasthenia-gravistreatment-market In May 2019, the American Academy of Neurology had approved Eculizumab (Soliris), a particularly high-cost biologic that treats rare and ultra-rare diseases to make treatment of myasthenia gravis patients. Therefore, the emergence of new biologics is expected to drive the growth of the global myasthenia market. Ongoing R&D by government or non-government institutions to find new ways to treat autoimmune disorders is anticipated to offer considerable opportunities to the growth of the global market. However, the high cost of treatment is anticipated to hinder the growth of the myasthenia gravis treatment market across the globe. Browse

for

Full

Report

Description@

https://www.omrglobal.com/industry-

reports/myasthenia-gravis-treatment-market Market Segmentation Global Myasthenia Gravis Treatment Market by Treatment Medication 

Cholinesterase Inhibitors



Corticosteroids



Immunosuppressants



Surgery



Others

Global Myasthenia Gravis Treatment Market by End-User 

Hospitals



Clinics



Other

Regional Analysis North America 

US



Canada

Europe 

UK



Germany



Italy



Spain



France



Rest of Europe

Asia-Pacific 

China



India



Japan



Rest of Asia-Pacific

Rest of the World Company Profiles 

AbbVie, Inc.



Alexion Pharmaceutical, Inc.



Amneal Pharmaceuticals, Inc.



Argenx SE



Astellas Pharma, Inc.



Avadel Pharmaceuticals PLC



Bausch Health Companies Inc.



Baxter International, Inc.



CSL Behring



CuraVac, Inc.



F. Hoffmann-La Roche, Ltd.



GlaxoSmithKline plc



Grifols SA



Immunovant, Inc.



Mitsubishi Tanabe Pharma Corp.



Novartis AG



RA Pharmaceuticals, Inc.



Takeda Pharmaceutical Co., Ltd.



UCB Pharma



Valeant Pharmaceuticals International, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/myasthenia-gravis-treatment-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +91 780-304-0404